تأثیر سن بر شیوع نشانگرهای HBV در جمعیت آذر کوهورت

Impact of age on the prevalence of HBV markers among Azar Cohort population


چاپ صفحه
پژوهان
صفحه نخست سامانه
نویسندگان
نویسندگان
اطلاعات تفضیلی
اطلاعات تفضیلی
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: علی اصغر پوری , محمد حسین صومی , مرتضی قوجازاده

عنوان کنگره / همایش: بیست و چهارمین کنگره بیماری های گوارش و کبد ایران , Iran (Islamic Republic) , تهران , 2024

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله علی اصغر پوری
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه بیماری های گوارش و کبد
کد مقاله 89470
عنوان فارسی مقاله تأثیر سن بر شیوع نشانگرهای HBV در جمعیت آذر کوهورت
عنوان لاتین مقاله Impact of age on the prevalence of HBV markers among Azar Cohort population
نوع ارائه پوستر
عنوان کنگره / همایش بیست و چهارمین کنگره بیماری های گوارش و کبد ایران
نوع کنگره / همایش بین المللی
کشور محل برگزاری کنگره/ همایش Iran (Islamic Republic)
شهر محل برگزاری کنگره/ همایش تهران
سال انتشار/ ارائه شمسی 1403
سال انتشار/ارائه میلادی 2024
تاریخ شمسی شروع و خاتمه کنگره/همایش 1403/09/13 الی 1403/09/16
آدرس لینک مقاله/ همایش در شبکه اینترنت
آدرس علمی (Affiliation) نویسنده متقاضی Liver and Gastrointestinal Diseases Research Center Tabriz University of Medical Sciences ,Tabriz,Iran

نویسندگان
hide/show

نویسنده نفر چندم مقاله
علی اصغر پوریاول
محمد حسین صومیدوم
مرتضی قوجازادهسوم

اطلاعات تفضیلی
hide/show

عنوان متن
کلمات کلیدیHBV,HBsAg,HBsAb,Azar Cohort
خلاصه مقالهIntroduction: Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV) that affects the liver. The spectrum of clinical manifestations of hepatitis B virus (HBV) infection varies in both acute and chronic disease. Most people only have a brief, acute infection. But for some people, it becomes chronic. During the chronic phase, manifestations range from an asymptomatic carrier state to chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Hepatitis B is preventable with a vaccine, but it has no cure. The aim of this study was to determine the prevalence of HBV seropositivity among age groups in Azar Cohort population. Methods and Materials: This was a population – based study, using random cluster sampling 4949 healthy subjects of both genders between 35-70 years of age were included during 2015-2016 in east Azerbaijan, Iran. Questionnaires including some demographic characteristics were administered to participants. Serum samples were tested for hepatitis B markers including HBsAg, and HBsAb by using the third generation of ELISA test. Data were analyzed with SPSS version 19.0. Results: The mean age of hepatitis positive patients was 50.06 ± 9.14 years. Of these participants, 54.3% (n= 2686) were females. Out of 51 HBsAg positive patients, 14 patients (27.45%) based on the evidence of laboratory had transaminitis and 37 patients (72.55%) were without transaminitis. The prevalence of HBsAg in age groups <40, 40-50, 50-60 and >60 were 0.86%, 0.98%, 1.2% and 1.03% respectively. The prevalence of HBsAb in age groups <40, 40-50, 50-60 and >60 were 13.3%, 16.3%, 18.2% and 21.4% respectively. The prevalence of HBsAg in the age group of 50-60 years was higher than other age groups. In this study, we did not find any significant association between frequency of HBsAg and age (P=0.94). There was a significant association between frequency of HBsAb and age group (p<0.001). Discussion & Conclusions: According to our results, the prevalence of HBsAg in different age groups were lower than with the results reported from other studies. In addition, religious background, and the relationship between the increase in public awareness and the increase in the level of health of the population under study in result was impressive.

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
certificate HBV.pdf1404/10/15132170دانلود
HBV.JPG1404/10/152156779دانلود